An instrument is demonstrated that is capable of three-dimensional (3D) vasculature imaging and pO 2 quantification with high spatial resolution. The instrument combines two-photon (2P) microscopy with phosphorescence quenching to measure pO 2 . The instrument was demonstrated by performing depth-resolved microvascular pO 2 measurements of rat cortical vessels down to 120 m below the surface. 2P excitation of porphyrin was confirmed, and measured pO 2 values were consistent with previously published data for normoxic and hyperoxic conditions. The ability to perform 3D pO 2 measurements using optical techniques will allow researchers to overcome existing limitations imposed by polarographic electrodes, magnetic resonance techniques, and surface-only pO 2 measurement techniques. © 2008 Optical Society of America OCIS codes: 170.0110, 170.1460 Because oxygen is vital to the metabolic processes of all eukaryotic cells, a detailed understanding of its transport and consumption is of great interest to researchers. Current methods for in vivo measurement of intravascular and tissue dissolved oxygen concentration ͑pO 2 ͒ at the cellular level are nonideal. Either they lack the three-dimensional (3D) spatial resolution desired, are invasive and disturb the local physiology, or they rely on hemoglobin spectrophotometry, which is not a direct measure of the oxygen available to cells. It has been suggested that combining two-photon (2P) excitation with the pO 2 quantification via phosphorescence quenching [1,2] could lead to a new method that is well suited for high resolution pO 2 measurement in vitro and in vivo [3] .
Because oxygen is vital to the metabolic processes of all eukaryotic cells, a detailed understanding of its transport and consumption is of great interest to researchers. Current methods for in vivo measurement of intravascular and tissue dissolved oxygen concentration ͑pO 2 ͒ at the cellular level are nonideal. Either they lack the three-dimensional (3D) spatial resolution desired, are invasive and disturb the local physiology, or they rely on hemoglobin spectrophotometry, which is not a direct measure of the oxygen available to cells. It has been suggested that combining two-photon (2P) excitation with the pO 2 quantification via phosphorescence quenching [1, 2] could lead to a new method that is well suited for high resolution pO 2 measurement in vitro and in vivo [3] .
The phosphorescence quenching technique relies on changes in the phosphorescence lifetime of a molecular probe as it is quenched by oxygen. pO 2 quantification based on this principle has been shown to be an effective and accurate method for measuring dissolved pO 2 both in tissue and vasculature [4] [5] [6] [7] . The relationship between lifetime and pO 2 is described by the Stern-Volmer equation 1 / =1/ 0 + k q pO 2 , where is the measured phosphorescence lifetime, 0 is the lifetime of the phosphor under zerooxygen conditions, and k q is the quenching constant. Porphyrin-based oxygen probes are typically used for this type of application because porphyrin is known to be exclusively quenched by oxygen and its use in vivo has been well established in literature [1, 2, [4] [5] [6] [7] [8] . These types of probes have long lifetimes (ϳ100 s of s) and quenching constant values that make them well suited for measurement of physiological pO 2 .
Combining 2P microscopy with oxygen determination via phosphorescence quenching would in principle have micrometer-scale resolution, have inherent 3D sectioning, and provide absolute pO 2 values. Although Mik et al. [8] demonstrated the proof of concept by measuring in vivo tissue pO 2 along the axial direction using a 2P excited phosphorescence lifetime technique, to our knowledge there have been no reports in the literature of combining 2P imaging with pO 2 sensing using phosphorescence quenching in vivo. This is most probably due to the low 2P action cross section of porphyrin [3] and the timing mismatch between the repetition rate of common 2P excitation sources (nanosecond) and the porphyrin lifetime (microsecond). In this Letter, we describe and demonstrate an instrument that combines 2P microscopy with pO 2 quantification using 2P excited phosphorescence quenching. The instrument is capable of simultaneous 3D imaging of microvasculature and image-guided measurement of intravascular pO 2 .
3D image-guided pO 2 measurements are possible because of the simple introduction of an acousto-optic modulator (AOM) to a standard 2P microscope set up to serve as a temporal gate to the laser pulse train (Fig. 1 ). The AOM (NEOS Technologies 23080-2-LTD) is needed to overcome the timing mismatch between the phosphorescence lifetime of porphyrin in vivo ͑50-200 s͒ and the time between pulses from our 2P excitation source ͑ϳ13 ns͒. Light ͑ = 780 nm͒ from a Ti:sapphire oscillator (Coherent Mira 900, 10 W pump) is passed through the AOM under computer control. The first-order diffracted beam is directed to beam conditioning optics, to galvanometer scanning mirrors (Galvos model, Cambridge), and finally to an objective (40ϫ 0.7 NA water immersion). In imaging mode, a continuous voltage is applied to the AOM, and the pulse train from our excitation source is completely transmitted to the microscope. However, in pO 2 measurement mode, the AOM is made to gate the pulse train with a duty cycle of 1% and a repetition rate of 1 kHz. Fluorescence and phosphorescence signals are detected by a photomultiplier tube (PMT) (H7422P-50, Hamamtsu Corp.). Acquisition of phosphorescence decays was synchronized with gating of the AOM, enabling multiple excitation events to be quickly averaged to improve the signal-to-noise ratio (SNR) as needed.
To demonstrate the capabilities of this new instrument, we simultaneously mapped a region of vasculature and performed intravascular pO 2 measurements of rat somatosensory cortex while the fraction of inspired oxygen ͑FiO 2 ͒ was varied. Spraguedawley rats were anesthetized for surgery with urethane (1.5, 0.3 g / kg supplements as needed) by intraperitoneal injection and an intravenous line inserted into the femoral vein. The skull and dura were removed over a 3 mmϫ 3 mm area. A well was created around the exposed area, filled with agarose, then sealed with a coverslip that was secured to the stereotaxic frame with a metal coverslip holder as described elsewhere [9] . Dextran-conjugated fluorescein was intravenously injected at a concentration of 83 mg/ kg for visualization of cortical vasculature. A solution of 28 mg/ ml Oxyphor R2 (Oxygen Enterprises) and 20 mg/ ml of BSA (BP671-10 Fisher Scientific) dissolved in physiologic saline was created, and 3 ml/ kg of this solution was then intravenously injected. Sequences of vasculature images were recorded from the fluorescein emission at different depths. From these images multiple points within individual vessels were interactively selected for pO 2 measurements using our software. The selected points were translated to galvanometer positions and 2000 phosphorescence decay curves were recorded at each location and averaged together. Because of a transimpedance amplifier with limited bandwidth and an AOM driver with a slow turn-off time, the first 50 s of data was discarded so as to ignore any artifacts from scattered excitation light. A single exponential decay model was fit to the average phosphorescence decay curve at each location to determine the phosphorescence lifetime. Using published values for the porphyrin quenching constant and unquenched lifetime [10] , the lifetimes were converted to pO 2 values using the Stern-Volmer relationship. pO 2 measurements were taken at various depths. At each depth location the FiO 2 was varied and pO 2 data were acquired.
With in vitro experiments we verified that the presence of fluorescein had no effect on the porphyrin lifetime at the concentrations used in vivo. The phosphorescence lifetime was measured in the absence of oxygen and found to be unchanged, and to approximately match reported values ͑ϳ500 s͒ [4] . In vitro experiments also confirmed 2P excitation of porphyrin by observing that the phosphorescence intensity varied as the square of the excitation intensity [ Fig.  2(g) ]. Figure 2 shows typical results for cortical vessels under normoxic and hyperoxic conditions at depths of 120 and 100 m. The figure depicts vasculature images at two locations with pO 2 measurement overlays for the two FiO 2 conditions. Vasculature imaging was done using a power of ϳ3 mW, and pO 2 measurements were taken with an average power of ϳ1.5-2 mW after the 1% duty cycling. Our combination of objective and laser wavelength resulted in an excitation focal volume of 0.5 m (radial) by 1.3 m (axial) in size. For intravascular pO 2 measurements, the focal volume moves downstream with the blood flow as it phosphoresces. Therefore, the spatial resolution of the pO 2 measurement is a function of the local flow rate and the lifetime of the probe at that location. For our experiments, we estimate the resolution to be ϳ10 m or better. The measured pO 2 values are in good agreement with values reported in the literature for arterioles under similar conditions [11] . Shonat et al. report pO 2 values of ϳ40 mmHg in the normoxia case and ϳ60 mmHg in the hyperoxia case (60% FiO 2 ) for rat cortical arterioles under similar anesthesia.
Figures 2(c) and 2(f) show the nature of the fitting of the averaged phosphorescence signals for the highlighted points within each image. The highlighted pO 2 measurements in Figs. 2(a) and 2(b) had standard errors of ±1.7 and ±3.5 mmHg, respectively, whereas the standard error of the pO 2 measurements highlighted in Figs. 2(d) and 2(e) were ±1.3 and ±1.6 mmHg, respectively. The standard error can be improved as needed by simply averaging more phosphorescence decay events at the expense of temporal resolution. We found that ϳ2000 decays was sufficient to produce an error of Ͻ2 mmHg for the majority of our in vivo measurements down to a depth of ϳ300 m across ten rats. For greater depths, more averaging is needed because of the SNR decrease caused by the loss of excitation intensity at the focal volume. The poor SNR that results from the low 2P cross section can also be mitigated to some extent by increased porphyrin concentration. We confirmed that for a given intravascular pO 2 , the measured decay lifetime did not vary with the concentration of porphyrin in the blood over a range from 130-430 M. Although these concentrations are relatively high compared to the conditions used to determine the reported [10] quenching constant and unquenched lifetime, these values do not seem to strongly vary with concentration. We estimate that we have a systematic error in our pO 2 calculation no greater than 10% as a result. To more accurately calculate pO 2 from the measured decay lifetime, one would need to perform a calibration of these parameters under similar high concentration conditions. As oxygen probes with higher 2P action cross sections become available, the SNR should improve. This will result in lower concentrations, lower average excitation power, and improved temporal resolution. Figure 3 further demonstrates the unique capabilities of the instrument. The image shows a branching vessel 58 m below the surface where one branch contains a highly localized occlusion. Red blood cell motion in the unoccluded branch shows up as an area of lower intensity since only the plasma is labeled. The pO 2 measurements indicate that oxygen is still able to reach the lower branch that is devoid of erythrocytes. However, the pO 2 values in that section are reduced and show a decreasing gradient as we move away from the unoccluded branch.
The instrument described in this Letter is distinct from other pO 2 sensing techniques in that it has the ability to provide image-guided depth-resolved pO 2 measurements at high resolution. Since only a simple modification to a standard 2P microscope setup is required, 3D pO 2 sensing capability can easily be incorporated into many existing 2P imaging setups. 
